Clinical Trials Directory

Trials / Unknown

UnknownNCT04430621

Effects of FSH on Endothelial Function (FEND)

Effects of Follicle-Stimulating Hormone Injection on Flow Mediated Dilation in Healthy Males

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
16 (estimated)
Sponsor
Federico II University · Academic / Other
Sex
Male
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

Purpose of the study will be to evaluate the effects of the s.c. administration of 300 IU of FSH in 16 healthy males. The endothelial function will be evaluated by the measurement with ecographic approach of the flow mediated dilation (FMD) of the brachial artery. The FMD will be measured before and 6, 12, 24 or 48 hours after FSH or placebo adiministration in the same subjects studied 2 weeks apart. The results will help to clarify whether perturbation of FSH, similar to the one observed in women after the menopause, affect endothelial function.

Detailed description

The effects of follicle-stimulating hormone (FSH) have been poorly studied. In women, FSH is involved in estrogen production, while in men regulates spermatogenesis. On the other hand, in women, menopause is associated with an increase in the risk of cardiovascular disease and the concentration of FSH rises. It is unclear whether such an increase has any effect on the development of atherosclerosis. Endothelial dysfunction represents an early trigger of atherosclerosis. Since estrogens can directly stimulate endothelial function and increase in response to FSH administration, males might represent a potential model to study the effcts of FSH independent from estrogens.Purpose of the study will be to evaluate the effects of the s.c. administration of 300 IU of FSH in 16 healthy males. The endothelial function will be evaluated by the measurement with ecographic approach of the flow mediated dilation (FMD) of the brachial artery. The FMD will be measured before and 6, 12, 24 or 48 hours after FSH or placebo adiministration in the same subjects studied 2 weeks apart. The results will help to clarify whether perturbation of FSH, similar to the one observed in women after the menopause, affects endothelial function.

Conditions

Interventions

TypeNameDescription
DRUGFollicle Stimulating HormoneFSH will be administered s.c. in the morning to male healthy subjects

Timeline

Start date
2020-07-01
Primary completion
2020-08-10
Completion
2020-08-31
First posted
2020-06-12
Last updated
2020-06-12

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT04430621. Inclusion in this directory is not an endorsement.